• BUSINESS ENQUIRY :
  • +91 80122 78000
  • BUSINESS ENQUIRY :
  • 044 4032 9999 / 044 4020 5050

Business Enquiry :

+91 80122 78000

Business Enquiry :

044 4032 9999 / 044 4020 5050

IPO : Unihealth Consultancy Limited

IPO : Unihealth Consultancy Limited
  • By Goodwill
  • 1,458 Comments
  • September 12, 2023

IPO : Unihealth Consultancy Limited

Unihealth Consultancy Limited IPO

Incorporated in 2010, Unihealth Consultancy Limited is a healthcare service provider based out of Mumbai, India, and has an operational presence in multiple countries across the African continent.

Unihealth Consultancy’s business segments include Medical Centres, Hospitals, Consultancy Services, Distribution of Pharmaceutical and medical Consumable Products, and Medical Value Travel. It operates a combined capacity of 200 operational hospital beds across two multi-specialty facilities i.e. UMC Victoria Hospital in Kampala, Uganda, has a bed strength of 120 beds, and UMC Zhahir Hospital in Kano, Nigeria has a bed strength of 80 beds. In addition to these, it operates ‘Unihealth Medical Centre’ a dedicated dialysis facility, in Mwanza, Tanzania.

    •  SYMBOL UNIHEALTH
       ISSUE TYPE Book Built Issue IPO
       ISSUE OPENS ON September 08, 2023 (Friday)
       ISSUE CLOSES ON September 12, 2023 (Tuesday)
       ISSUE PRICE Rs.126 To Rs.132 per share
       ISSUE SIZE Up to Rs.56.55 Crores
       FACE VALUE Rs.10 per share

      The company is currently providing Project Management Consultancy Services to set up a 300+ bedded Health City in Undri, Pune (Maharashtra, India) for PHRC Lifespaces Organization along with a few other healthcare consultancy projects in Kenya and Angola.

       MINIMUM BID 1000 shares
       MINIMUM AMOUNT  Rs.1,32,000
       MAXIMUM BID 1000 shares
       MAXIMUM AMOUNT  Rs.1,32,000
       LISTING DATE September 21,2023 (Thursday)
       LISTING AT NSE-SME

      Unihealth Pharmaceuticals Private Limited, a subsidiary of the company, is in the business of procuring and exporting pharmaceutical and medical consumable products. The Company exports and supplies these products mainly to Victoria Hospital Limited (Joint Venture of Unihealth Consultancy Limited) in Uganda, UMC Global Health Limited (Joint-Venture of Unihealth Consultancy Limited) in Nigeria and 114 Biohealth Limited (Subsidiary of Unihealth Consultancy Limited) in Tanzania.

      The company’s clientele comes from countries like India, Uganda, Nigeria & Tanzania, Kenya, Zimbabwe & Angola and Ethiopia, Mozambique & DR Congo.

      Objects of the Issue

      The company intends to utilize the net proceeds from the issue towards the funding of the following objects:

      1. Investment in the joint venture, Victoria Hospital Limited (VHL), Kampala, Uganda for funding its capital expenditure requirements for proposed expansion and working capital requirements of VHL.
      2. Investment in the joint venture, UMC Global Health Limited (UMCGHL), Nigeria for funding its capital expenditure requirements for the proposed expansion.
      3. Investment in the subsidiary, Biohealth Limited (BL), Tanzania for funding its capital expenditure requirements for the proposed expansion.
      4. General corporate purposes.
    • SMART IPO using UPI, you can now apply online
      For Existing Clients : https://gudwil.in/IPO
      Open an account :  https://gudwil.in/smart      Further any clarification, feel free to contact your Branch / Relationship Manager.For all your investment needs feel free to reach us. Give us a missed call at 90037 90027. For Support: 044-40329999Warm Regards,
      Team GoodwillDISCLAIMER : Investments in the securities market are subject to market risk. Read all the related documents carefully before investing. The data and information herein provided are believed to be reliable, but Goodwill Wealth Management Pvt. Ltd., does not warrant its accuracy or completeness. Goodwill Wealth Management Pvt. Ltd., or any of its employees are not liable for any action taken by any party based on the above information. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Special note: Short-term trading on the basis of technical is high risk and skill-oriented venture and may result in huge losses also. Traders doing so are doing at their own risk. We are not responsible for any damages. Note: The material is being provided to you for educational purposes only and does not constitute investment advice; returns mentioned herein are in no way a guarantee or promise of future returns. See Disclaimer, Privacy Policy @ https://gwcindia.in/Disclaimer

Risk Disclosures
on Derivatives

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Attention Investor

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. Prevent Unauthorized Transactions in your Demat account\Trading account: Update your Mobile Number with your Depository Participant\Exchange. Receive alerts on your Registered Mobile for all debit and other important transactions in your Demat account\Trading account directly from Depository\Exchange on the same day………issued in the interest of investors.
The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us.
Please DO NOT disclose your User ID and/or Passwords to any person, even Goodwill staff never ask you to share the same. Goodwill is NEITHER liable for any loss arising from your sharing of your password with anyone, NOR from its consequent unauthorized use.

Invest In

Others

 

Important Links

Useful Links

Flow Chart

Policy

 

Investor Complaints

Important Links

Get Social

Facebook Twitter Youtube
Goodwill Wealth Management Pvt Ltd |       MCX : 11095 | SEBI Regn. No : INZ000177036
Clearing Code |       NSE : M52003 | BSE : 6648
CDSL DP |       DP ID : 12084200 | SEBI Regn. No : IN - DP - CDSL - 309 - 2017
Research Analyst |       SEBI Regn. No : INH200005179
Mutual Funds |  ARN : 182218

Proprietary Trading Disclosure:In terms of provisions of the Rules, Bye-Laws and Business Rules of the Exchange and with reference to circular MCX/T&S/147/2016 dated May 17, 2016 regarding Disclosure of Proprietary Account Trading by broker to client.,Pursuant to SEBI Circular Number SEBI/MRD/SEC/Cir-42/2003 dated November 19, 2003 & SEBI/HO/CDMRD/DMP/CIR/P/2016/49 dated April 25, 2016 GOODWILL WEALTH MANAGEMENT PVT LTD. Discloses to its clients about its policies on proprietary trades.